019170.KS · 신풍제약
South Korea · RS rating 61 · As of 2026-10-14
| Price | 9,600.00 KRW |
|---|---|
| 1-day change | +1.7% |
| RS rating (overall / 1M / 3M / 12M) | 61 / 52 / 79 / 34 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 21 / 9 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | -2633.3% |
| Sales growth Q/Q | +17.2% |
| Distance from 52-week high | +38.8% |
| Market cap (USD) | $391.2M |